Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-Dose Methotrexate for Ectopic Pregnancy
NCT00194272Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Mar 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methotrexate in Ectopic pregnancy (EP), sponsored by University of Pennsylvania. Primary endpoint: Prevalence of side effects. Started Mar 2001; status: completed.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT00194272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194272.